Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.

@article{Lew2008TherapeuticUO,
  title={Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.},
  author={Henry L. Lew and Eun Ha Lee and Annabel Castaneda and Roger Klima and Elaine S Date},
  journal={Archives of physical medicine and rehabilitation},
  year={2008},
  volume={89 1},
  pages={75-80}
}
OBJECTIVE To determine the efficacy of botulinum toxin type A (BTX-A) in treating neck and upper-back pain of myofascial origin. DESIGN A randomized, double-blind, placebo-controlled pilot study. SETTING Outpatient physical medicine and rehabilitation clinic of a university-affiliated tertiary hospital. PARTICIPANTS A total of 29 subjects enrolled from among 45 screened patients. No subject withdrawal due to serious adverse events occurred. INTERVENTION Subjects were evaluated at… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Effect of Hyaluronidase Addition to Lidocaine for Trigger Point Injection in Myofascial Pain Syndrome.

Pain practice : the official journal of World Institute of Pain • 2016
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: a rch

H Gobel, A Heinze, G Reichel, H Hefter, R. Benecke
Phys Med Rehabil Vol • 2008
View 1 Excerpt

Expanding use of botulinum toxin

M Porta, G Maggioni
J Neurol Sci • 2005

Botuli - num toxin type A for the treatment of chronic neck pain after neck dissection

B Jabbari, J Ney, +3 authors M Difazio
Head Neck • 2004

Similar Papers

Loading similar papers…